
Pharmaceutical development
Let us improve your research and development of pharmaceuticals
With the right active ingredient and the right dosage form to create a new pharmacological effect!
We support you, through our network, in the planning, conceptual design, and implementation of drug development programs that optimally prepare your active ingredient and deliver it to the desired site of action through the appropriate mode (transdermal, parenteral, oral dosage forms, etc.). Efficacy studies (in virto trials, preclinical) are necessary to prove the pharmacological effect.
Our range of services includes pharmaceutical drug development, testing of highly innovative galenic carrier systems for targeted drug targeting and pharmaceutical technology, membrane technology, process engineering, and pharmaceutical biotechnology.
We optimize drug dosage forms through excellent galenics from raw material screening, raw material selection, formulation discovery, manufacturing technology and performing stability testing. Depending on the requirements, our partner network also helps with instrumental analytics for quality testing and content determination with chromatography (UHPLC, HPLC, IC, HS-GC, DC, etc).
We, as well as our contract laboratories, provide analytical-regulatory advice, and find the suitable contract manufacturer, and accompany you through the management of the project to an efficient implementation.
In the field of clinical trials, we also have partners for the development of suitable drug products in early phases (e.g., active ingredient in vial or capsule form, targeted formulations). In addition, we will be pleased to accompany you from stability analysis to the preparation of registration documentation.
We support you from the product idea to the entire implementation of an innovative drug. Feel free to contact us!
Our services in drug development:
Galenic redevelopment of various dosage forms
Formulation and process optimization
Immediate release
and depot preparations
Processing of poorly soluble active ingredients
Aromatization of solid
and liquid dosage forms
Active substance selection
Combination drugs
with 2 to 3 active ingredients (505(b)(2))